Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP353791.RACYlE0tpgtHqxJ1vNvc6pLVtPyf3i9uzF23xe3FydHSA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP353791.RACYlE0tpgtHqxJ1vNvc6pLVtPyf3i9uzF23xe3FydHSA130_assertion type Assertion NP353791.RACYlE0tpgtHqxJ1vNvc6pLVtPyf3i9uzF23xe3FydHSA130_head.
- NP353791.RACYlE0tpgtHqxJ1vNvc6pLVtPyf3i9uzF23xe3FydHSA130_assertion description "[BCMA is a suitable target for CAR-expressing T cells, and adoptive transfer of anti-BCMA-CAR-expressing T cells is a promising new strategy for treating multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353791.RACYlE0tpgtHqxJ1vNvc6pLVtPyf3i9uzF23xe3FydHSA130_provenance.
- NP353791.RACYlE0tpgtHqxJ1vNvc6pLVtPyf3i9uzF23xe3FydHSA130_assertion evidence source_evidence_literature NP353791.RACYlE0tpgtHqxJ1vNvc6pLVtPyf3i9uzF23xe3FydHSA130_provenance.
- NP353791.RACYlE0tpgtHqxJ1vNvc6pLVtPyf3i9uzF23xe3FydHSA130_assertion SIO_000772 23344265 NP353791.RACYlE0tpgtHqxJ1vNvc6pLVtPyf3i9uzF23xe3FydHSA130_provenance.
- NP353791.RACYlE0tpgtHqxJ1vNvc6pLVtPyf3i9uzF23xe3FydHSA130_assertion wasDerivedFrom befree-20140225 NP353791.RACYlE0tpgtHqxJ1vNvc6pLVtPyf3i9uzF23xe3FydHSA130_provenance.
- NP353791.RACYlE0tpgtHqxJ1vNvc6pLVtPyf3i9uzF23xe3FydHSA130_assertion wasGeneratedBy ECO_0000203 NP353791.RACYlE0tpgtHqxJ1vNvc6pLVtPyf3i9uzF23xe3FydHSA130_provenance.